Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolperisone PK and Dose Linearity in Healthy Subjects
NCT04465266Phase 1Completed
- Sponsor
- Neurana Pharmaceuticals, Inc.
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of tolperisone in Muscle spasm (3 arms), sponsored by Neurana Pharmaceuticals, Inc. Primary endpoints: Maximum Plasma Concentration at Day 4, Time to Maximum Plasma Concentration at Day 4 and 2 more. Started Jul 2020; status: completed.
02
Drugs
tolperisone
03
Conditions
Muscle spasm
Beyond the preview
Go deeper on NCT04465266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465266.